abciximab

From (F)_ab +‎ -ci- (“cardiovascular”) +‎ -ximab (“chimeric monoclonal antibody”).

• (General American) IPA^(key): /æbˈsɪk.sɪˌmæb/

abciximab (uncountable)

1. (pharmacology) A powerful anticlotting drug (trademark ReoPro) that inhibits platelet aggregation by binding to a glycoprotein receptor on human platelets and that consists of the F_ab fragment from a chimeric monoclonal antibody prepared from humans and mice.

• “abciximab”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.

Unadapted borrowing from English abciximab.

abciximab m (invariable)

1. abciximab

abciximab m (uncountable)

1. (pharmacology) abciximab (antiplatelet drug)

• IPA^(key): /abθiɡsiˈmab/ [aβ̞.θiɣ̞.siˈmaβ̞] (Spain, Equatorial Guinea)
• IPA^(key): /absiɡsiˈmab/ [aβ̞.siɣ̞.siˈmaβ̞] (Latin America, Philippines)
• Rhymes: -ab
• Syllabification: ab‧ci‧xi‧mab

abciximab m (uncountable)

1. (pharmacology) abciximab